Surgical Education — Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina
Citation(s)
Aziz H, James T, Remulla D, Sher L, Genyk Y, Sullivan ME, Sheikh MR Effect of COVID-19 on Surgical Training Across the United States: A National Survey of General Surgery Residents. J Surg Educ. 2020 Jul 30. pii: S1931-7204(20)30271-3. doi: 10.1016/j.jsurg.2020.07.037. [Epub ahead of print]
Kapila AK, Schettino M, Farid Y, Ortiz S, Hamdi M The Impact of Coronavirus Disease 2019 on Plastic Surgery Training: The Resident Perspective. Plast Reconstr Surg Glob Open. 2020 Jul 1;8(7):e3054. doi: 10.1097/GOX.0000000000003054. eCollection 2020 Jul.
Kogan M, Klein SE, Hannon CP, Nolte MT Orthopaedic Education During the COVID-19 Pandemic. J Am Acad Orthop Surg. 2020 Jun 1;28(11):e456-e464. doi: 10.5435/JAAOS-D-20-00292. Review.
Pelargos PE, Chakraborty A, Zhao YD, Smith ZA, Dunn IF, Bauer AM An Evaluation of Neurosurgical Resident Education and Sentiment During the Coronavirus Disease 2019 Pandemic: A North American Survey. World Neurosurg. 2020 Aug;140:e381-e386. doi: 10.1016/j.wneu.2020.05.263. Epub 2020 Jun 5.
Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina: A Cross-sectional Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
